Epidermal growth factor receptor signalling seems to have an important role in pancreatic cancer tumour progression and EGFR, at least in theory, has been deemed an attractive molecular target for pancreatic cancer treatment (Fjallskog et al, 2003). The gene discussed is EGFR; the disease is familial pancreatic carcinoma.